HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis
HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. The post HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis appeared first on Medical Device Network.
HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias.
The post HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis appeared first on Medical Device Network.
